Sales & Marketing The B2C prescription: Marketing lessons for B2B pharma compa... B2B is often seen to lag behind B2C in marketing, and nowhere is that more true than in the pharmaceuticals industry.
News GSK's Walmsley could sell off sports products - reports GlaxoSmithKline’s new CEO Emma Walmsley is set to outline her vision for the company alongside half-year results next month – but reports suggest that she may shake up the consumer products
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.